PFE Financial Facts

Basic (in shares): 6.16B
Research and development expenses: 1.73B
See Full Income Statement

Accumulated other comprehensive loss: -8.52B
Other noncurrent liabilities: 5.31B
See Full Balance Sheet

Pfizer Inc. (PFE) Earnings

  |   Expand Research on PFE
Next EPS Date 10/28/15 *Est. EPS Growth Rate -3.4% *Last Qtr.
Average EPS % Beat Rate +4.3% Revenue Growth Rate -14.1% *Last Qtr.
Average % Move 1-Wk after EPS +1.3% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
1/29/13 Q412 $0.47$0.44 +$0.03$15.1B$14.4B = Details
2/1/11 Q410 $0.47$0.46 +$0.01$17.56B$16.97B = Details
1/31/12 Q411 $0.50$0.47 +$0.03$16.7B$16.61B = Details
4/28/15 Q115 $0.51$0.49 +$0.02$10.86B$10.79B Details
11/2/10 Q310 $0.54$0.51 +$0.03N/AN/A N/A Details
1/28/14 Q413 $0.56$0.52 +$0.04$13.56B$13.35B = Details
7/28/15 Q215 $0.56$0.52 +$0.04$11B$11.42B Details
1/27/15 Q414 $0.54$0.53 +$0.01$13.1B$12.94B Details